Financial Tearsheet

Company Overview

Recent Financial News

Date   Headline
Oct 06, 2020 Aytu BioScience Announces Fiscal Q4 2020 Net Revenue of $14.9 Million, an Increase of 82% Sequentially, and 766% Year-Over-Year
Oct 05, 2020 Aytu BioScience to Report Fourth Quarter and Full Year Fiscal 2020 Results and Provide Business Update on Tuesday, October 6, 2020
Sep 23, 2020 Aytu BioScience to Reschedule Fourth Quarter and FY 2020 Conference Call
Sep 16, 2020 Aytu BioScience to Report Fourth Quarter FY 2020 Results and Business Update on Thursday, September 24, 2020
Sep 08, 2020 Aytu BioScience Announces Global Agreement to Distribute Pinnacle IVD Corporation's 15-Minute COVID-19 Antigen Test

IR Contacts

Hayden IR

James Carbonara
1441 Broadway
Fifth Floor
New York, NY 10018
Office: (646)-755-7412
James@haydenir.com

Stock Performance

Today's Open 0.9866
Volume 544,226
Day Range 0.9777 - 1.0000
52 Week Range 0.3352 - 2.9900
Bid/Ask 0.9992 / 0.9999
Bid/Ask Size 800 X 700
Previous Close 0.9902
Market Cap 125.84 million
Shares Outstanding 125.84 million
Dividend/Yield 0.0000 / 0.0000%
EPS (TTM) -0.512700
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
Oct 06, 2020 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
May 15, 2020 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Feb 14, 2020 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Nov 14, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Sep 26, 2019 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

Josh Disbrow, Chairman & Chief Executive Officer

Jarrett Disbrow, Chief Operating Officer

David Green, Chief Financial Officer

Board of Directors

Josh Disbrow, Chairman & Chief Executive Officer

Gary Cantrell, Director, Chair, Compensation Committee

Carl Dockery, Director, Chair, Nominating & Governance Committee

John Donofrio, Jr., Director, Chair, Audit Committee

Michael Macaluso, Director